Carlos Cordon-Cardo Department of Pathology Icahn School of Medicine at Mount Sinai Biography Publications Institution JoVE Articles Carlos Cordon-Cardo has not added a biography. If you are Carlos Cordon-Cardo and would like to personalize this page please email our Author Liaison for assistance. Publications Myocardial Amyloid Quantification with Look-Locker Magnetic Resonance Sequence in Cardiac Amyloidosis. Diagnostic Accuracy in Clinical Practice and Histological Validation Journal of Cardiac Failure. Aug, 2017 | Pubmed ID: 28801077 Erratum: The Metabolic Co-regulator PGC1α Suppresses Prostate Cancer Metastasis Nature Cell Biology. Jun, 2017 | Pubmed ID: 28659639 MTORC1-dependent AMD1 Regulation Sustains Polyamine Metabolism in Prostate Cancer Nature. Jul, 2017 | Pubmed ID: 28658205 PTEN Counteracts FBXL2 to Promote IP3R3- and Ca(2+)-mediated Apoptosis Limiting Tumour Growth Nature. Jun, 2017 | Pubmed ID: 28614300 Targeting Sarcoma Tumor-initiating Cells Through Differentiation Therapy Stem Cell Research. May, 2017 | Pubmed ID: 28433655 MiR-424(322)/503 is a Breast Cancer Tumor Suppressor Whose Loss Promotes Resistance to Chemotherapy Genes & Development. Mar, 2017 | Pubmed ID: 28404630 The Nuclear Transport Receptor Importin-11 is a Tumor Suppressor That Maintains PTEN Protein The Journal of Cell Biology. Mar, 2017 | Pubmed ID: 28193700 Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes Molecular Diagnosis & Therapy. Apr, 2017 | Pubmed ID: 28000172 Reappraising Hyalinizing Clear Cell Carcinoma: A Population-based Study with Molecular Confirmation Head & Neck. Mar, 2017 | Pubmed ID: 27898192 The Role of GATA2 in Lethal Prostate Cancer Aggressiveness Nature Reviews. Urology. Jan, 2017 | Pubmed ID: 27872477 Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis Via Androgen Receptor Signaling The American Journal of Pathology. Dec, 2016 | Pubmed ID: 27770613 Protein Profiling of Bladder Urothelial Cell Carcinoma PloS One. 2016 | Pubmed ID: 27626805 The Metabolic Co-regulator PGC1α Suppresses Prostate Cancer Metastasis Nature Cell Biology. 06, 2016 | Pubmed ID: 27214280 Urachal Carcinoma Shares Genomic Alterations with Colorectal Carcinoma and May Respond to Epidermal Growth Factor Inhibition European Urology. Nov, 2016 | Pubmed ID: 27178450 Enrichment of Cells with Cancer Stem Cell-Like Markers in Relapses of Chemoresistant Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Oncology. 2016 | Pubmed ID: 27077749 Immunopathologic Assessment of PTEN Expression Methods in Molecular Biology (Clifton, N.J.). 2016 | Pubmed ID: 27033068 H-RAS Mutation is a Key Molecular Feature of Pediatric Urothelial Bladder Cancer. A Detailed Report of Three Cases Journal of Pediatric Urology. Apr, 2016 | Pubmed ID: 26522772 Metabolic Reprogramming Induces Resistance to Anti-NOTCH1 Therapies in T Cell Acute Lymphoblastic Leukemia Nature Medicine. Oct, 2015 | Pubmed ID: 26390244 Expression of the Cancer Testis Antigen IGF2BP3 in Colorectal Cancers; IGF2BP3 Holds Promise As a Specific Immunotherapy Target Oncoscience. 2015 | Pubmed ID: 26244168 Inhibition of the Autocrine IL-6-JAK2-STAT3-calprotectin Axis As Targeted Therapy for HR-/HER2+ Breast Cancers Genes & Development. Aug, 2015 | Pubmed ID: 26227964 PI3K/AKT Pathway Regulates E-cadherin and Desmoglein 2 in Aggressive Prostate Cancer Cancer Medicine. Aug, 2015 | Pubmed ID: 26033689 MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis Due to IL6 Secretion and AKT Suppression Via PHLPP2 Cancer Discovery. Jun, 2015 | Pubmed ID: 25829425 Methodological Aspects of the Molecular and Histological Study of Prostate Cancer: Focus on PTEN Methods (San Diego, Calif.). May, 2015 | Pubmed ID: 25697760 A Targetable GATA2-IGF2 Axis Confers Aggressiveness in Lethal Prostate Cancer Cancer Cell. Feb, 2015 | Pubmed ID: 25670080 Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis Cancer Discovery. May, 2015 | Pubmed ID: 25653093 A Genetic Platform to Model Sarcomagenesis from Primary Adult Mesenchymal Stem Cells Cancer Discovery. Apr, 2015 | Pubmed ID: 25614485 Massive Parallel Sequencing Uncovers Actionable FGFR2-PPHLN1 Fusion and ARAF Mutations in Intrahepatic Cholangiocarcinoma Nature Communications. 2015 | Pubmed ID: 25608663 Limited MiR-17-92 Overexpression Drives Hematologic Malignancies Leukemia Research. Mar, 2015 | Pubmed ID: 25597017 Loss of Sirt1 Promotes Prostatic Intraepithelial Neoplasia, Reduces Mitophagy, and Delays PARK2 Translocation to Mitochondria The American Journal of Pathology. Jan, 2015 | Pubmed ID: 25529796 ΔNp63 Expression is a Protective Factor of Progression in Clinical High Grade T1 Bladder Cancer The Journal of Urology. Apr, 2015 | Pubmed ID: 25444981 Biomarkers for Bladder Cancer Management: Present and Future American Journal of Clinical and Experimental Urology. 2014 | Pubmed ID: 25374904 Overcoming Tumor Heterogeneity in the Molecular Diagnosis of Urological Cancers Expert Review of Molecular Diagnostics. Nov, 2014 | Pubmed ID: 25327491 The MicroRNA 424/503 Cluster Reduces CDC25A Expression During Cell Cycle Arrest Imposed by Transforming Growth Factor β in Mammary Epithelial Cells Molecular and Cellular Biology. Dec, 2014 | Pubmed ID: 25266660 Bladder Cancers Arise from Distinct Urothelial Sub-populations Nature Cell Biology. Oct, 2014 | Pubmed ID: 25218638 A NOTCH1-driven MYC Enhancer Promotes T Cell Development, Transformation and Acute Lymphoblastic Leukemia Nature Medicine. Oct, 2014 | Pubmed ID: 25194570 Characterization of Desmoglein Expression in the Normal Prostatic Gland. Desmoglein 2 is an Independent Prognostic Factor for Aggressive Prostate Cancer PloS One. 2014 | Pubmed ID: 24896103 FBXW7 Mutations in Melanoma and a New Therapeutic Paradigm Journal of the National Cancer Institute. Jun, 2014 | Pubmed ID: 24838835 Defining the Role of CD2 in Disease Progression and Overall Survival Among Patients with Completely Resected Stage-II to -III Cutaneous Melanoma Journal of the American Academy of Dermatology. Jun, 2014 | Pubmed ID: 24698703 The MiR-424(322)/503 Cluster Orchestrates Remodeling of the Epithelium in the Involuting Mammary Gland Genes & Development. Apr, 2014 | Pubmed ID: 24636986 Genomic Analysis in Active Surveillance: Predicting High-risk Disease Using Tissue Biomarkers Current Opinion in Urology. May, 2014 | Pubmed ID: 24625431 RapidCaP, a Novel GEM Model for Metastatic Prostate Cancer Analysis and Therapy, Reveals Myc As a Driver of Pten-Mutant Metastasis Cancer Discovery. Mar, 2014 | Pubmed ID: 24444712 Direct Reversal of Glucocorticoid Resistance by AKT Inhibition in Acute Lymphoblastic Leukemia Cancer Cell. Dec, 2013 | Pubmed ID: 24291004 Zbtb7a Suppresses Prostate Cancer Through Repression of a Sox9-dependent Pathway for Cellular Senescence Bypass and Tumor Invasion Nature Genetics. Jul, 2013 | Pubmed ID: 23727861 A Co-clinical Approach Identifies Mechanisms and Potential Therapies for Androgen Deprivation Resistance in Prostate Cancer Nature Genetics. Jul, 2013 | Pubmed ID: 23727860 Dual Pten/Tp53 Suppression Promotes Sarcoma Progression by Activating Notch Signaling The American Journal of Pathology. Jun, 2013 | Pubmed ID: 23708211 Loss of PML Cooperates with Mutant P53 to Drive More Aggressive Cancers in a Gender-dependent Manner Cell Cycle (Georgetown, Tex.). Jun, 2013 | Pubmed ID: 23656786 Predicting High-risk Disease Using Tissue Biomarkers Current Opinion in Urology. May, 2013 | Pubmed ID: 23478499 A Common MicroRNA Signature Consisting of MiR-133a, MiR-139-3p, and MiR-142-3p Clusters Bladder Carcinoma in Situ with Normal Umbrella Cells The American Journal of Pathology. Apr, 2013 | Pubmed ID: 23410519 Compound In Vivo Inactivation of Pml and P53 Uncovers a Functional Interaction in Angiosarcoma Suppression Genes & Cancer. Sep, 2012 | Pubmed ID: 23486996 MAGE-A3 is Highly Expressed in a Subset of Colorectal Cancer Patients Cancer Immunity. 2012 | Pubmed ID: 23390371 Suppression of Acquired Docetaxel Resistance in Prostate Cancer Through Depletion of Notch- and Hedgehog-dependent Tumor-initiating Cells Cancer Cell. Sep, 2012 | Pubmed ID: 22975379 Targeting Nonclassical Oncogenes for Therapy in T-ALL Cancer Cell. Apr, 2012 | Pubmed ID: 22516257 Preclinical Analysis of the γ-secretase Inhibitor PF-03084014 in Combination with Glucocorticoids in T-cell Acute Lymphoblastic Leukemia Molecular Cancer Therapeutics. Jul, 2012 | Pubmed ID: 22504949 A BAC-based Transgenic Mouse Specifically Expresses an Inducible Cre in the Urothelium PloS One. 2012 | Pubmed ID: 22496911 Translocation Renal Cell Carcinomas in Adults: a Single-institution Experience The American Journal of Surgical Pathology. May, 2012 | Pubmed ID: 22446944 Perioperative Polyphenon E, a Green Tea Extract, Does Not Affect the Wound Complication Rate in Mice After Sham Laparotomy Yet Has an Inhibitory Effect on Wound Healing Surgical Innovation. Dec, 2012 | Pubmed ID: 22431911 MiR-143, MiR-222, and MiR-452 Are Useful As Tumor Stratification and Noninvasive Diagnostic Biomarkers for Bladder Cancer The American Journal of Pathology. May, 2012 | Pubmed ID: 22426337 PAX7-FKHR Fusion Gene Inhibits Myogenic Differentiation Via NF-kappaB Upregulation Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. Mar, 2012 | Pubmed ID: 22374423 PPARγ Agonists Enhance ET-743-induced Adipogenic Differentiation in a Transgenic Mouse Model of Myxoid Round Cell Liposarcoma The Journal of Clinical Investigation. Mar, 2012 | Pubmed ID: 22293175 Postoperative Systems Models More Accurately Predict Risk of Significant Disease Progression Than Standard Risk Groups and a 10-year Postoperative Nomogram: Potential Impact on the Receipt of Adjuvant Therapy After Surgery BJU International. Jan, 2012 | Pubmed ID: 21771247 A Systems-based Modelling Approach Using Transurethral Resection of the Prostate (TURP) Specimens Yielded Incremental Prognostic Significance to Gleason when Predicting Long-term Outcome in Men with Localized Prostate Cancer BJU International. Jan, 2012 | Pubmed ID: 21733075 A Comparison of the Outcomes of Neoadjuvant and Adjuvant Chemotherapy for Clinical T2-T4aN0-N2M0 Bladder Cancer Cancer. Jan, 2012 | Pubmed ID: 21717438 CpG ODN, Toll Like Receptor (TLR)-9 Agonist, Inhibits Metastatic Colon Adenocarcinoma in a Murine Hepatic Tumor Model The Journal of Surgical Research. May, 2012 | Pubmed ID: 21324492 Personalized Approach to Prostate Cancer Prognosis Archivos Españoles De Urología. Oct, 2011 | Pubmed ID: 22052759 Anatomical Features of the Urethra and Urinary Bladder Catheterization in Female Mice and Rats. An Essential Translational Tool Acta Cirúrgica Brasileira / Sociedade Brasileira Para Desenvolvimento Pesquisa Em Cirurgia. 2011 | Pubmed ID: 22030824 Predictive Value of Microtubule Associated Proteins Tau and Stathmin in Patients with Nonmuscle Invasive Bladder Cancer Receiving Adjuvant Intravesical Taxane Therapy The Journal of Urology. Nov, 2011 | Pubmed ID: 21944130 Identification of PHLPP1 As a Tumor Suppressor Reveals the Role of Feedback Activation in PTEN-mutant Prostate Cancer Progression Cancer Cell. Aug, 2011 | Pubmed ID: 21840483 A Role for PML in Innate Immunity Genes & Cancer. Jan, 2011 | Pubmed ID: 21779477 KISS1 Methylation and Expression As Tumor Stratification Biomarkers and Clinical Outcome Prognosticators for Bladder Cancer Patients The American Journal of Pathology. Aug, 2011 | Pubmed ID: 21683672 Alternate PAX3 and PAX7 C-terminal Isoforms in Myogenic Differentiation and Sarcomagenesis Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. Mar, 2011 | Pubmed ID: 21421465 Distinct Expression Profiles of P63 Variants During Urothelial Development and Bladder Cancer Progression The American Journal of Pathology. Mar, 2011 | Pubmed ID: 21356385 Three-dimensional Culture of Mouse Renal Carcinoma Cells in Agarose Macrobeads Selects for a Subpopulation of Cells with Cancer Stem Cell or Cancer Progenitor Properties Cancer Research. Feb, 2011 | Pubmed ID: 21266363 Hydrophilic Agarose Macrobead Cultures Select for Outgrowth of Carcinoma Cell Populations That Can Restrict Tumor Growth Cancer Research. Feb, 2011 | Pubmed ID: 21266362 Disruption of a Sirt1-dependent Autophagy Checkpoint in the Prostate Results in Prostatic Intraepithelial Neoplasia Lesion Formation Cancer Research. Feb, 2011 | Pubmed ID: 21189328 Mouse Models of Human Bladder Cancer As a Tool for Drug Discovery Current Protocols in Pharmacology / Editorial Board, S.J. Enna (editor-in-chief) ... [et Al.]. Jun, 2010 | Pubmed ID: 22294368 The TLX1 Oncogene Drives Aneuploidy in T Cell Transformation Nature Medicine. Nov, 2010 | Pubmed ID: 20972433 Association of Nuclear Localization of a Long Interspersed Nuclear Element-1 Protein in Breast Tumors with Poor Prognostic Outcomes Genes & Cancer. Feb, 2010 | Pubmed ID: 20948976 Impact of Stromal Sensitivity on Radiation Response of Tumors Implanted in SCID Hosts Revisited Cancer Research. Oct, 2010 | Pubmed ID: 20924105 Molecular Pathways of Urothelial Development and Bladder Tumorigenesis Urologic Oncology. Jul-Aug, 2010 | Pubmed ID: 20610278 Integrative Genome Comparison of Primary and Metastatic Melanomas PloS One. 2010 | Pubmed ID: 20520718 Associations Between NBS1 Polymorphisms, Haplotypes and Smoking-related Cancers Carcinogenesis. Jul, 2010 | Pubmed ID: 20478923 Galectin-3 Expression is Associated with Bladder Cancer Progression and Clinical Outcome Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine. Aug, 2010 | Pubmed ID: 20401558 Skp2 Targeting Suppresses Tumorigenesis by Arf-p53-independent Cellular Senescence Nature. Mar, 2010 | Pubmed ID: 20237562 PHF6 Mutations in T-cell Acute Lymphoblastic Leukemia Nature Genetics. Apr, 2010 | Pubmed ID: 20228800 Single Nucleotide Polymorphisms of 8 Inflammation-related Genes and Their Associations with Smoking-related Cancers International Journal of Cancer. Journal International Du Cancer. Nov, 2010 | Pubmed ID: 20112337 Overexpression of Phospho-eIF4E is Associated with Survival Through AKT Pathway in Non-small Cell Lung Cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jan, 2010 | Pubmed ID: 20008839 Androgen Receptor Expression is Associated with Prostate Cancer-specific Survival in Castrate Patients with Metastatic Disease BJU International. Feb, 2010 | Pubmed ID: 19624594 MiR-19 is a Key Oncogenic Component of Mir-17-92 Genes & Development. Dec, 2009 | Pubmed ID: 20008935 Intravesical Delivery of Rapamycin Suppresses Tumorigenesis in a Mouse Model of Progressive Bladder Cancer Cancer Prevention Research (Philadelphia, Pa.). Dec, 2009 | Pubmed ID: 19952358 The N-Myc-DLL3 Cascade is Suppressed by the Ubiquitin Ligase Huwe1 to Inhibit Proliferation and Promote Neurogenesis in the Developing Brain Developmental Cell. Aug, 2009 | Pubmed ID: 19686682 MFH Classification: Differentiating Undifferentiated Pleomorphic Sarcoma in the 21st Century Expert Review of Anticancer Therapy. Aug, 2009 | Pubmed ID: 19671033 3-Phosphoinositide-dependent Kinase 1 Potentiates Upstream Lesions on the Phosphatidylinositol 3-kinase Pathway in Breast Carcinoma Cancer Research. Aug, 2009 | Pubmed ID: 19602588 Systems Pathology: a Paradigm Shift in the Practice of Diagnostic and Predictive Pathology Cancer. Jul, 2009 | Pubmed ID: 19544549 Cyfip1 is a Putative Invasion Suppressor in Epithelial Cancers Cell. Jun, 2009 | Pubmed ID: 19524508 Personalized Prediction of Tumor Response and Cancer Progression on Prostate Needle Biopsy The Journal of Urology. Jul, 2009 | Pubmed ID: 19450827 Prediction of Prostate Cancer Recurrence Using Magnetic Resonance Imaging and Molecular Profiles Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jun, 2009 | Pubmed ID: 19435838 Aberrant ERG Expression Cooperates with Loss of PTEN to Promote Cancer Progression in the Prostate Nature Genetics. May, 2009 | Pubmed ID: 19396168 A Systems Pathology Model for Predicting Overall Survival in Patients with Refractory, Advanced Non-small-cell Lung Cancer Treated with Gefitinib European Journal of Cancer (Oxford, England : 1990). May, 2009 | Pubmed ID: 19272767 Inactivation of P53 and Pten Promotes Invasive Bladder Cancer Genes & Development. Mar, 2009 | Pubmed ID: 19261747 Correlation of MR Imaging and MR Spectroscopic Imaging Findings with Ki-67, Phospho-Akt, and Androgen Receptor Expression in Prostate Cancer Radiology. Mar, 2009 | Pubmed ID: 19244047 ETS Rearrangements and Prostate Cancer Initiation Nature. Feb, 2009 | Pubmed ID: 19212347 Differential Requirement of MTOR in Postmitotic Tissues and Tumorigenesis Science Signaling. 2009 | Pubmed ID: 19176516 Gamma-secretase Inhibitors Reverse Glucocorticoid Resistance in T Cell Acute Lymphoblastic Leukemia Nature Medicine. Jan, 2009 | Pubmed ID: 19098907 Comparison of Models to Predict Clinical Failure After Radical Prostatectomy Cancer. Jan, 2009 | Pubmed ID: 19025977 Alveolar Rhabdomyosarcoma: is the Cell of Origin a Mesenchymal Stem Cell? Cancer Letters. Jul, 2009 | Pubmed ID: 19008039 Identification of PMF1 Methylation in Association with Bladder Cancer Progression Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Dec, 2008 | Pubmed ID: 19088041 P53 is Localized to a Sub-nucleolar Compartment After Proteasomal Inhibition in an Energy-dependent Manner Journal of Cell Science. Dec, 2008 | Pubmed ID: 19033390 Associations Between Variants of the 8q24 Chromosome and Nine Smoking-related Cancer Sites Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. Nov, 2008 | Pubmed ID: 18990762 Molecular Alterations Associated with Bladder Cancer Initiation and Progression Scandinavian Journal of Urology and Nephrology. Supplementum. Sep, 2008 | Pubmed ID: 18815930 Targeting AKT/mTOR and ERK MAPK Signaling Inhibits Hormone-refractory Prostate Cancer in a Preclinical Mouse Model The Journal of Clinical Investigation. Sep, 2008 | Pubmed ID: 18725989 Systems Pathology Approach for the Prediction of Prostate Cancer Progression After Radical Prostatectomy Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Aug, 2008 | Pubmed ID: 18711180 Aberrant Rheb-mediated MTORC1 Activation and Pten Haploinsufficiency Are Cooperative Oncogenic Events Genes & Development. Aug, 2008 | Pubmed ID: 18708577 Chk2 Suppresses the Oncogenic Potential of DNA Replication-associated DNA Damage Molecular Cell. Jul, 2008 | Pubmed ID: 18614044 DLC1 is a Chromosome 8p Tumor Suppressor Whose Loss Promotes Hepatocellular Carcinoma Genes & Development. Jun, 2008 | Pubmed ID: 18519636 Gli Activity Correlates with Tumor Grade in Platelet-derived Growth Factor-induced Gliomas Cancer Research. Apr, 2008 | Pubmed ID: 18381430 A Developmental Model of Sarcomagenesis Defines a Differentiation-based Classification for Liposarcomas The American Journal of Pathology. Apr, 2008 | Pubmed ID: 18310505 TREK-1 is a Novel Molecular Target in Prostate Cancer Cancer Research. Feb, 2008 | Pubmed ID: 18281496 A Context Dependent Role for Wnt Signaling in Tumorigenesis and Stem Cells Cell Cycle (Georgetown, Tex.). Mar, 2008 | Pubmed ID: 18239459 Bax and Bak Do Not Exhibit Functional Redundancy in Mediating Radiation-induced Endothelial Apoptosis in the Intestinal Mucosa International Journal of Radiation Oncology, Biology, Physics. Mar, 2008 | Pubmed ID: 18191336 Genomic and Proteomic Profiles Reveal the Association of Gelsolin to TP53 Status and Bladder Cancer Progression The American Journal of Pathology. Nov, 2007 | Pubmed ID: 17982131 Derivation of Sarcomas from Mesenchymal Stem Cells Via Inactivation of the Wnt Pathway The Journal of Clinical Investigation. Nov, 2007 | Pubmed ID: 17948129 Somatic Cell Type Specific Gene Transfer Reveals a Tumor-promoting Function for P21(Waf1/Cip1) The EMBO Journal. Nov, 2007 | Pubmed ID: 17948060 Declining P53 Function in the Aging Process: a Possible Mechanism for the Increased Tumor Incidence in Older Populations Proceedings of the National Academy of Sciences of the United States of America. Oct, 2007 | Pubmed ID: 17921246 Mutational Loss of PTEN Induces Resistance to NOTCH1 Inhibition in T-cell Leukemia Nature Medicine. Oct, 2007 | Pubmed ID: 17873882 Identification of S664 TSC2 Phosphorylation As a Marker for Extracellular Signal-regulated Kinase Mediated MTOR Activation in Tuberous Sclerosis and Human Cancer Cancer Research. Aug, 2007 | Pubmed ID: 17671177 Highly Efficient Gene Delivery for Bladder Cancers by Intravesically Administered Replication-competent Retroviral Vectors Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Aug, 2007 | Pubmed ID: 17671137 Tissue-specific and Reversible RNA Interference in Transgenic Mice Nature Genetics. Jul, 2007 | Pubmed ID: 17572676 Improved Prediction of Prostate Cancer Recurrence Through Systems Pathology The Journal of Clinical Investigation. Jul, 2007 | Pubmed ID: 17557117 Prognostic Significance of P27Kip1 Expression in Bladder Cancer BJU International. Aug, 2007 | Pubmed ID: 17555476 A Polymorphism in HDM2 (SNP309) Associates with Early Onset in Superficial Tumors, TP53 Mutations, and Poor Outcome in Invasive Bladder Cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jun, 2007 | Pubmed ID: 17545525 The AKT-mTOR Pathway Plays a Critical Role in the Development of Leiomyosarcomas Nature Medicine. Jun, 2007 | Pubmed ID: 17496901 Molecular Alterations Associated with Bladder Cancer Progression Seminars in Oncology. Apr, 2007 | Pubmed ID: 17382791 Role of the Chromobox Protein CBX7 in Lymphomagenesis Proceedings of the National Academy of Sciences of the United States of America. Mar, 2007 | Pubmed ID: 17374722 Relation Between Human Papillomavirus Positivity and P16 Expression in Head and Neck Carcinomas--a Tissue Microarray Study Anticancer Research. Jan-Feb, 2007 | Pubmed ID: 17352245 Hyperactivation of Ha-ras Oncogene, but Not Ink4a/Arf Deficiency, Triggers Bladder Tumorigenesis The Journal of Clinical Investigation. Feb, 2007 | Pubmed ID: 17256055 Senescence and Tumour Clearance is Triggered by P53 Restoration in Murine Liver Carcinomas Nature. Feb, 2007 | Pubmed ID: 17251933 Ubiquitination Regulates PTEN Nuclear Import and Tumor Suppression Cell. Jan, 2007 | Pubmed ID: 17218261 NEDD4-1 is a Proto-oncogenic Ubiquitin Ligase for PTEN Cell. Jan, 2007 | Pubmed ID: 17218260 Technology Insight: Will Systems Pathology Replace the Pathologist? Nature Clinical Practice. Urology. Jan, 2007 | Pubmed ID: 17211424 Mad2 Overexpression Promotes Aneuploidy and Tumorigenesis in Mice Cancer Cell. Jan, 2007 | Pubmed ID: 17189715 Alterations of the Retinoblastoma and P16 Pathway Correlate with Promoter Methylation in Malignant Fibrous Histiocytomas Anticancer Research. Sep-Oct, 2006 | Pubmed ID: 17094467 Evaluation of Ki67, P53 and Angiogenesis in Patients Enrolled in a Randomized Study of Neoadjuvant Chemotherapy with or Without Cystectomy: a Southwest Oncology Group Study Oncology Reports. Oct, 2006 | Pubmed ID: 16969498 PML Inhibits HIF-1alpha Translation and Neoangiogenesis Through Repression of MTOR Nature. Aug, 2006 | Pubmed ID: 16915281 Determinants of Sensitivity and Resistance to Rapamycin-chemotherapy Drug Combinations in Vivo Cancer Research. Aug, 2006 | Pubmed ID: 16885364 Analysis of DNA Mismatch Repair Gene Expression and Mutations in Thyroid Tumours Anticancer Research. May-Jun, 2006 | Pubmed ID: 16827152 Altered Expression of DNA Double-strand Repair Genes Ku70 and Ku80 in Carcinomas of the Oral Cavity Anticancer Research. May-Jun, 2006 | Pubmed ID: 16827151 Comparative Oncogenomics Identifies NEDD9 As a Melanoma Metastasis Gene Cell. Jun, 2006 | Pubmed ID: 16814714 Identification and Validation of Oncogenes in Liver Cancer Using an Integrative Oncogenomic Approach Cell. Jun, 2006 | Pubmed ID: 16814713 Autocrine PDGFR Signaling Promotes Mammary Cancer Metastasis The Journal of Clinical Investigation. Jun, 2006 | Pubmed ID: 16741576 Identification of a Tumour Suppressor Network Opposing Nuclear Akt Function Nature. May, 2006 | Pubmed ID: 16680151 Loss of Ku70/Ku80 Expression Occurs More Frequently in Hereditary Than in Sporadic Colorectal Tumors. Tissue Microarray Study Human Pathology. Apr, 2006 | Pubmed ID: 16564919 Defining Molecular Profiles of Poor Outcome in Patients with Invasive Bladder Cancer Using Oligonucleotide Microarrays Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Feb, 2006 | Pubmed ID: 16432078 Amplification of CDK4 and MDM2 in Malignant Melanoma Genes, Chromosomes & Cancer. May, 2006 | Pubmed ID: 16419059 Profiling Bladder Cancer Using Targeted Antibody Arrays The American Journal of Pathology. Jan, 2006 | Pubmed ID: 16400012 Differential Exoprotease Activities Confer Tumor-specific Serum Peptidome Patterns The Journal of Clinical Investigation. Jan, 2006 | Pubmed ID: 16395409 [Molecular Protocol for HER2/neu Analysis in Breast Carcinoma] Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. Dec, 2005 | Pubmed ID: 16373062 A Novel Logistic Model Based on Clinicopathological Features Predicts Microsatellite Instability in Colorectal Carcinomas Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B. Dec, 2005 | Pubmed ID: 16319691 Proposal of a New Grading System for Malignant Fibrous Histiocytomas Anticancer Research. Nov-Dec, 2005 | Pubmed ID: 16309231 Relationship of Nm23 Expression to Proliferation and Prognosis in Malignant Melanomas of the Oral Cavity In Vivo (Athens, Greece). Nov-Dec, 2005 | Pubmed ID: 16277028 Tobacco Smoking, GSTP1 Polymorphism, and Bladder Carcinoma Cancer. Dec, 2005 | Pubmed ID: 16240451 A Novel Multiplexing, Polymerase Chain Reaction-based Assay for the Analysis of Chromosome 18q Status in Colorectal Cancer The Journal of Molecular Diagnostics : JMD. Oct, 2005 | Pubmed ID: 16237217 Gene Expression Profiling in Single Cells Within Tissue Nature Methods. Sep, 2005 | Pubmed ID: 16118636 Evasion of the P53 Tumour Surveillance Network by Tumour-derived MYC Mutants Nature. Aug, 2005 | Pubmed ID: 16094360 Expression of P63 in Diffuse Large B-cell Lymphoma Applied Immunohistochemistry & Molecular Morphology : AIMM / Official Publication of the Society for Applied Immunohistochemistry. Sep, 2005 | Pubmed ID: 16082248 Cytokeratin Expression Correlates with Aneuploidy in Cytological Specimens of Melanoma Metastases Anticancer Research. Jul-Aug, 2005 | Pubmed ID: 16080528 Crucial Role of P53-dependent Cellular Senescence in Suppression of Pten-deficient Tumorigenesis Nature. Aug, 2005 | Pubmed ID: 16079851 Genetic Analysis of Pten and Tsc2 Functional Interactions in the Mouse Reveals Asymmetrical Haploinsufficiency in Tumor Suppression Genes & Development. Aug, 2005 | Pubmed ID: 16027168 A MicroRNA Polycistron As a Potential Human Oncogene Nature. Jun, 2005 | Pubmed ID: 15944707 A Phase I Clinical Trial of the Sequential Combination of Irinotecan Followed by Flavopiridol Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. May, 2005 | Pubmed ID: 15897584 Drg1 Expression in 131 Colorectal Liver Metastases: Correlation with Clinical Variables and Patient Outcomes Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. May, 2005 | Pubmed ID: 15867226 P73beta-Mediated Apoptosis Requires P57kip2 Induction and IEX-1 Inhibition Cancer Research. Mar, 2005 | Pubmed ID: 15781630 Celecoxib Inhibits Prostate Cancer Growth: Evidence of a Cyclooxygenase-2-independent Mechanism Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Mar, 2005 | Pubmed ID: 15756026 Safety and Biologic Activity of Intravenous BCL-2 Antisense Oligonucleotide (G3139) and Taxane Chemotherapy in Patients with Advanced Cancer Applied Immunohistochemistry & Molecular Morphology : AIMM / Official Publication of the Society for Applied Immunohistochemistry. Mar, 2005 | Pubmed ID: 15722787 Role of the Proto-oncogene Pokemon in Cellular Transformation and ARF Repression Nature. Jan, 2005 | Pubmed ID: 15662416 Molecular Profiling of Tumor Progression in Head and Neck Cancer Archives of Otolaryngology--head & Neck Surgery. Jan, 2005 | Pubmed ID: 15655179 Application of in Situ Hybridization Probes for MLH-1 and MSH-2 in Tissue Microarrays of Paraffin-embedded Malignant Melanomas: Correlation with Immunohistochemistry and Tumor Stage Human Pathology. Dec, 2004 | Pubmed ID: 15619215 Role of Dok-1 and Dok-2 in Leukemia Suppression The Journal of Experimental Medicine. Dec, 2004 | Pubmed ID: 15611295 Racial Disparity of Epidermal Growth Factor Receptor Expression in Prostate Cancer Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Dec, 2004 | Pubmed ID: 15570072 Glutathione S-transferase P1 Ile105Val Polymorphism, Cigarette Smoking and Prostate Cancer Cancer Detection and Prevention. 2004 | Pubmed ID: 15542263 Genetic and Immunophenotype Analyses of TP53 in Bladder Cancer: TP53 Alterations Are Associated with Tumor Progression Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B. Dec, 2004 | Pubmed ID: 15538112 Cytokeratin Positivity in Paraffin-embedded Malignant Melanomas: Comparative Study of KL1, A4 and Lu5 Antibodies Anticancer Research. Sep-Oct, 2004 | Pubmed ID: 15510611 Rb Inactivation Promotes Genomic Instability by Uncoupling Cell Cycle Progression from Mitotic Control Nature. Aug, 2004 | Pubmed ID: 15306814 Preclinical Validation of Anti-TMEFF2-auristatin E-conjugated Antibodies in the Treatment of Prostate Cancer Molecular Cancer Therapeutics. Aug, 2004 | Pubmed ID: 15299075 Caenorhabditis Elegans ABL-1 Antagonizes P53-mediated Germline Apoptosis After Ionizing Irradiation Nature Genetics. Aug, 2004 | Pubmed ID: 15273685 Comparison of DNA Ploidy Status and DNA Ploidy-related Parameters in Malignant Melanoma Tissue Microarrays and Full Sections Human Pathology. Jul, 2004 | Pubmed ID: 15257554 Analysis of Adenomatous Polyposis Coli Gene Expression, APC Locus-microsatellite Instability and APC Promoter Methylation in the Progression of Melanocytic Tumours Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc. Dec, 2004 | Pubmed ID: 15257316 Hyperphosphorylation of PRb: a Mechanism for RB Tumour Suppressor Pathway Inactivation in Bladder Cancer The Journal of Pathology. Jul, 2004 | Pubmed ID: 15221935 High-resolution Characterization of the Pancreatic Adenocarcinoma Genome Proceedings of the National Academy of Sciences of the United States of America. Jun, 2004 | Pubmed ID: 15199222 Altered Expression and New Mutations in DNA Mismatch Repair Genes MLH1 and MSH2 in Melanoma Brain Metastases Anticancer Research. Mar-Apr, 2004 | Pubmed ID: 15161053 The Translation Factor EIF-4E Promotes Tumor Formation and Cooperates with C-Myc in Lymphomagenesis Nature Medicine. May, 2004 | Pubmed ID: 15098029 Survival Signalling by Akt and EIF4E in Oncogenesis and Cancer Therapy Nature. Mar, 2004 | Pubmed ID: 15029198 Inhibition of Orthotopic Human Bladder Tumor Growth by Lentiviral Gene Transfer of Endostatin Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Mar, 2004 | Pubmed ID: 15014038 Decreased Retinoid X Receptor-alpha Protein Expression in Basal Cells Occurs in the Early Stage of Human Prostate Cancer Development Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. Mar, 2004 | Pubmed ID: 15006913 Application of New in Situ Hybridization Probes for Ku70 and Ku80 in Tissue Microarrays of Paraffin-embedded Malignant Melanomas: Correlation with Immunohistochemical Analysis Human Pathology. Feb, 2004 | Pubmed ID: 14991539 P53 and RB: Simple Interesting Correlates or Tumor Markers of Critical Predictive Nature? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Mar, 2004 | Pubmed ID: 14981108 Histone Deacetylase Inhibitors: Assays to Assess Effectiveness in Vitro and in Vivo Methods in Enzymology. 2004 | Pubmed ID: 14975307 Loss of the Tumor Suppressor PML in Human Cancers of Multiple Histologic Origins Journal of the National Cancer Institute. Feb, 2004 | Pubmed ID: 14970276 MDM2 and Prognosis Molecular Cancer Research : MCR. Jan, 2004 | Pubmed ID: 14757840 Mutations of the PML Tumor Suppressor Gene in Acute Promyelocytic Leukemia Blood. Mar, 2004 | Pubmed ID: 14630830 Pten Dose Dictates Cancer Progression in the Prostate PLoS Biology. Dec, 2003 | Pubmed ID: 14691534 P73 Expression in Human Normal and Tumor Tissues: Loss of P73alpha Expression is Associated with Tumor Progression in Bladder Cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Nov, 2003 | Pubmed ID: 14654547 Comparison of Gene Expression Profiles in Laser-microdissected, Nonembedded, and OCT-embedded Tumor Samples by Oligonucleotide Microarray Analysis Clinical Chemistry. Dec, 2003 | Pubmed ID: 14633888 Genetic Signatures of Differentiation Induced by 1alpha,25-dihydroxyvitamin D3 in Human Colon Cancer Cells Cancer Research. Nov, 2003 | Pubmed ID: 14633706 P73alpha Regulation by Chk1 in Response to DNA Damage Molecular and Cellular Biology. Nov, 2003 | Pubmed ID: 14585975 Tumor Promotion by Mdm2 Splice Variants Unable to Bind P53 Cancer Research. Sep, 2003 | Pubmed ID: 14522887 Pharmacologic Inactivation of Kinase Suppressor of Ras-1 Abrogates Ras-mediated Pancreatic Cancer Nature Medicine. Oct, 2003 | Pubmed ID: 12960962 Adrenocortical Adenoma and Carcinoma: Histopathological and Molecular Comparative Analysis Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc. Aug, 2003 | Pubmed ID: 12920217 Tumor Suppressor Role for Myopodin in Bladder Cancer: Loss of Nuclear Expression of Myopodin is Cell-cycle Dependent and Predicts Clinical Outcome Oncogene. Aug, 2003 | Pubmed ID: 12917631 Classification and Subtype Prediction of Adult Soft Tissue Sarcoma by Functional Genomics The American Journal of Pathology. Aug, 2003 | Pubmed ID: 12875988 Gene Discovery in Bladder Cancer Progression Using CDNA Microarrays The American Journal of Pathology. Aug, 2003 | Pubmed ID: 12875971 Altered Expression of P27 and Skp2 Proteins in Prostate Cancer of African-American Patients Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jul, 2003 | Pubmed ID: 12855638 A Multigenic Program Mediating Breast Cancer Metastasis to Bone Cancer Cell. Jun, 2003 | Pubmed ID: 12842083 Oncogenes in Melanoma Oncogene. May, 2003 | Pubmed ID: 12789285 Array-based Comparative Genomic Hybridization for Genome-wide Screening of DNA Copy Number in Bladder Tumors Cancer Research. Jun, 2003 | Pubmed ID: 12782593 Lack of P53 Nuclear Immunostaining is Not Indicative of Absence of TP53 Gene Mutations in Colorectal Adenocarcinomas Applied Immunohistochemistry & Molecular Morphology : AIMM / Official Publication of the Society for Applied Immunohistochemistry. Jun, 2003 | Pubmed ID: 12777996 Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis Science (New York, N.Y.). May, 2003 | Pubmed ID: 12750523 Изоляция и характеристика опухолевых клеток от саркомы пациента полученных Xenografts Dan Han1, Veronica Rodriguez-Bravo1, Sudeh Izadmehr1, Josep Domingo-Domenech1, Carlos Cordon-Cardo1 1Department of Pathology, Icahn School of Medicine at Mount Sinai JoVE 57011 암 연구학 Поколение моделей клеток рака простаты сопротивления против митотическая агент доцетаксел Lisa Mohr1, Marc Carceles-Cordon1, Jungreem Woo1, Carlos Cordon-Cardo1, Josep Domingo-Domenech1, Veronica Rodriguez-Bravo1,2 1Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 2Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai JoVE 56327 암 연구학 Генерация пациента рака простаты Производные ксенотрансплантат модели от циркулирующих опухолевых клеток Estrelania S. Williams1, Veronica Rodriguez-Bravo3, Uma Chippada-Venkata2, Janis De Ia Iglesia-Vicente1, Yixuan Gong2, Matthew Galsky2, William Oh2, Carlos Cordon-Cardo1, Josep Domingo-Domenech1 1Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 2Department of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 3Molecular Biology Program, Memorial Sloan-Kettering Cancer Center 의학 Выделение стволовых клеток рака из образцов предстательной железы человека Samuel J. Vidal1, S. Aidan Quinn1, Janis de la Iglesia-Vicente1, Dennis M. Bonal1, Veronica Rodriguez-Bravo2, Adolfo Firpo-Betancourt1, Carlos Cordon-Cardo1, Josep Domingo-Domenech1 1Department of Pathology, Icahn School of Medicine at Mount Sinai, 2Molecular Biology Program, Memorial Sloan-Kettering Cancer Center JoVE 51332 의학
Изоляция и характеристика опухолевых клеток от саркомы пациента полученных Xenografts Dan Han1, Veronica Rodriguez-Bravo1, Sudeh Izadmehr1, Josep Domingo-Domenech1, Carlos Cordon-Cardo1 1Department of Pathology, Icahn School of Medicine at Mount Sinai JoVE 57011 암 연구학
Поколение моделей клеток рака простаты сопротивления против митотическая агент доцетаксел Lisa Mohr1, Marc Carceles-Cordon1, Jungreem Woo1, Carlos Cordon-Cardo1, Josep Domingo-Domenech1, Veronica Rodriguez-Bravo1,2 1Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 2Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai JoVE 56327 암 연구학
Генерация пациента рака простаты Производные ксенотрансплантат модели от циркулирующих опухолевых клеток Estrelania S. Williams1, Veronica Rodriguez-Bravo3, Uma Chippada-Venkata2, Janis De Ia Iglesia-Vicente1, Yixuan Gong2, Matthew Galsky2, William Oh2, Carlos Cordon-Cardo1, Josep Domingo-Domenech1 1Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 2Department of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 3Molecular Biology Program, Memorial Sloan-Kettering Cancer Center 의학
Выделение стволовых клеток рака из образцов предстательной железы человека Samuel J. Vidal1, S. Aidan Quinn1, Janis de la Iglesia-Vicente1, Dennis M. Bonal1, Veronica Rodriguez-Bravo2, Adolfo Firpo-Betancourt1, Carlos Cordon-Cardo1, Josep Domingo-Domenech1 1Department of Pathology, Icahn School of Medicine at Mount Sinai, 2Molecular Biology Program, Memorial Sloan-Kettering Cancer Center JoVE 51332 의학